Cargando…

OR17-3 Cartilage-Targeted IGF-1 Treatment to Promote Longitudinal Bone Growth

Recombinant human growth hormone (GH) is commonly used to treat short stature in children. However, GH treatment has limited efficacy particularly in severe, non-GH deficient conditions such as chondrodysplasias, and has potential off-target effects. Because short stature results from decreased grow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lui, Julian, Colbert, Max, Cheung, Crystal, Ad, Michal, Lee, Audrey, Zhu, Zhongyu, Barnes, Kevin, Dimitrov, Dimiter, Baron, Jeffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554759/ http://dx.doi.org/10.1210/js.2019-OR17-3

Ejemplares similares

SAT-283 A Mutation In Ccdc53 Affects Pth1r Trafficking And Causes Disproportionate Short Stature With Noonan-like Facies
por: Jee, Youn Hee, et al.
Publicado: (2019)

Impact of IGF-1 Normative Datasets on Indication and Outcome of Growth Hormone Stimulation Testing
por: de Bie, Prim, et al.
Publicado: (2021)

SAT-LB047 Circulating IGF-1, MKRN3, and Kisspeptin in Girls during the Onset of Puberty
por: Yang, Fan
Publicado: (2019)

THU176 Identification Of IGF1R Gene Variants In Short Children Born Small For Gestational Age
por: Kwon, Eun Byul, et al.
Publicado: (2023)

THU171 Reference Intervals For Bioavailable IGF-I Values In Dutch Healthy Children, Adolescents And Young Adults
por: Pellikaan, Karlijn, et al.
Publicado: (2023)

SUN-256 Limited Usefulness of Single IGF-I Measurement as a Screening Test for Growth Hormone Deficiency in Children and Adolescents
por: Ibba, Anastasia, et al.
Publicado: (2019)

SAT-090 Factors Affecting IGF-1 Level and Correlation with Growth Response During Growth Hormone Treatment in LGS Patients
por: Kim, Jihyun, et al.
Publicado: (2020)

THU174 Model-Based Analysis Of IGF-I Response, Dosing, And Monitoring For Once-Weekly Somapacitan In Children With GH Deficiency
por: Kildemoes, Rasmus Juul, et al.
Publicado: (2023)

OR07-5 A Cross-Sectional Study of IGF-I Bioavailability through Childhood: Associations with PAPP-A2 and Anthropometric Data
por: Fujimoto, Masanobu, et al.
Publicado: (2019)

THU157 Epigenetic Regulation Of Genes Involved In The Signaling Cascade Of The GH Axis - IGF1 And Insulin. Implication In Children Postnatal Growth
por: Zoff, Luciana, et al.
Publicado: (2023)

OR21-01 Pre-treatment Blood Transcriptome Predicts First-year Growth And IGF-I Response To Somapacitan Treatment In Children With GH Deficiency
por: Garner, Terence, et al.
Publicado: (2023)

Antibody-based therapeutics against components of the IGF system
por: Feng, Yang, et al.
Publicado: (2012)

OR17-5 Clinical and Genetic Features of Constitutional Delay of Growth and Puberty
por: Sales Barroso, Priscila, et al.
Publicado: (2019)

OR10-04 Interpretation of Insulin-like Growth Factor-1 (IGF-1) Levels Following Administration of Somatrogon (a Long-acting Human Growth Hormone - hGH-CTP)
por: Fisher, Dennis M, et al.
Publicado: (2020)

SAT-LB17 Triplication of SHOX Downstream Region in Mild Short Stature
por: Bunyan, David J, et al.
Publicado: (2020)

SAT-277 Re-Evaluation of the 17-Hydroxyprogesterone (17-OHP) Screening Threshold for Diagnosing Nonclassic Congenital Adrenal Hyperplasia (NCCAH) in the Era of Liquid Chromatography Tandem-Mass Spectrometry (LC-MS/MS)
por: Chesover, Alexander, et al.
Publicado: (2019)

OR17-1 Changes in the Hypothalamic-Pituitary-Adrenal Axis during Pediatric Critical Illness
por: Jacobs, An, et al.
Publicado: (2019)

OR17-2 Comprehensive Genetic Investigation of Patients with Central Precocious Puberty Associated with Complex Phenotypes
por: Canton, Ana, et al.
Publicado: (2019)

SUN-282 Sertraline-Induced Dyslipidemia and Liver Toxicity in a 17-Year-Old Adolescent
por: Dekelbab, Bassem, et al.
Publicado: (2019)

SUN-LB17 The Association of Growth Hormone Treatment in Children With Short Stature With Idiopathic Scoliosis
por: Nam, Hyo-Kyoung, et al.
Publicado: (2020)

MON-254 Fragility Fracture in a Pediatric Patient with Williams-Beuren Syndrome
por: Favela, Kristin, et al.
Publicado: (2019)

OR17-6 Parenteral Cephalosporins and Glucose During the Neonatal Period Are Associated with Pediatric Type 1 Diabetes Development
por: Zargari, Iren, et al.
Publicado: (2019)

SUN-291 17 Year Old Male with Galactorrhea and Elevations in Prolactin and ACTH in the Setting of a Pituitary Microadenoma
por: Nasir, Hamza, et al.
Publicado: (2019)

IGF-I, IGF-II, and Insulin Stimulate Different Gene Expression Responses through Binding to the IGF-I Receptor
por: Versteyhe, Soetkin, et al.
Publicado: (2013)

SAT-094 Evaluation of IGF-1 as a Biomarker to Inform Phase 3 Clinical Trial Design and Dose Selection in Patients Born Small for Gestational Age Who Fail to Demonstrate Catch-Up Growth by Age 2–4 Years
por: Liu, Tao, et al.
Publicado: (2020)

Longitudinal Investigation of Pubertal Milestones and Hormones as a Function of Body Fat in Girls
por: Ortega, Madison Taylor, et al.
Publicado: (2021)

OR17-4 Transcon Growth Hormone In The Treatment Of Pediatric Growth Hormone Deficiency: Results Of The Phase 3 Height Trial
por: Thornton, Paul, et al.
Publicado: (2019)

Craniofacial and Craniocervical Features in Cartilage-Hair Hypoplasia: A Radiological Study of 17 Patients and 34 Controls
por: Arponen, Heidi, et al.
Publicado: (2021)

OR17-1 MKRN3 Inhibits the Reproductive Axis by Interacting With Key Hypothalamic Substrates and Targeting Neurokinin B to Degradation Pathways.
por: Abreu, Ana Paula, et al.
Publicado: (2022)

OR21-03 Dose Responsiveness Of LUM-201 As Measured By Acute GH Response And IGF-1 And Annualized Height Velocity (AHV) Measured At 6 Months In The Interim Analysis Of The OraGrowtH212 Study In Idiopathic Pediatric Growth Hormone Deficiency (iPGHD)
por: Cassorla, Fernando, et al.
Publicado: (2023)

New Modulators for IGF-I Activity within IGF-I Processing Products
por: Brisson, Becky K., et al.
Publicado: (2013)

Lamprey IGF-Binding Protein-3 Has IGF-Dependent and -Independent Actions
por: Zhong, Yingbin, et al.
Publicado: (2017)

MON-066 17B-hydroxysteroid dehydrogenase Type 3 Deficiency: An Under-Recognized Cause of 46,XY DSD in the United States?
por: Whitehead, J, et al.
Publicado: (2020)

OR15-04 Accelerated Longitudinal Weight Gain Among Infants With In Utero COVID-19 Exposure
por: Ockene, Mollie W, et al.
Publicado: (2023)

OR18-3 Case Series of 16 Patients With 17β-Hydroxysteroid Dehydrogenase Type 3 Deficiency at Five Children's Hospitals in the United States
por: Endocrine & Genetics Working Groups, DSD-TRN, et al.
Publicado: (2022)

SAT-259 Natural History of Anthropometric Parametres of Obesity in Children Affected by X-Linked Hypophosphatemia: Longitudinal Obserbational Study
por: Zhukouskaya, Volha, et al.
Publicado: (2019)

SAT-098 The Impact of 17-OHP Cutoffs Determination in a Public Newborn Screening Program for Congenital Adrenal Hyperplasia in Southern Brazil: A Three Years’ Experience
por: Kopacek, Cristiane, et al.
Publicado: (2020)

SAT-LB051 Longitudinal Growth in Height and Changes in Body Proportions in Children with Hereditary Hypophosphatemic Rickets in a Single Center
por: Viterbo, Gisela, et al.
Publicado: (2019)

MON-103 Pattern and Predictors of Thyroid Dysfunction Among Paediatric Endocrine Referrals at Tertiary Care Centre: A Longitudinal Study
por: Masoodi, Shariq Rashid, et al.
Publicado: (2020)

Overexpression of IGF2 affects mouse weight and glycolipid metabolism and IGF2 is positively related to macrosomia
por: Zhang, Qidi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_if4digvajfpkmpq33gfnfnv9jc